Coffee Consumption and Gastric Cancer: A Pooled Analysis From the Stomach Cancer Pooling Project Consortium Publisher Pubmed



Martimianaki G^{1, 2} ; Bertuccio P³ ; Alicandro G⁴ ; Pelucchi C¹ ; Bravi F¹ ; Carioli G¹ ; Bonzi R¹ ; Rabkin CS⁵ ; Liao LM⁵ ; Sinha R⁵ ; Johnson K⁶ ; Hu J⁷ ; Palli D⁸ ; Ferraroni M¹ Show All Authors Show Affiliations
Source: European Journal of Cancer Prevention Published:2022

Abstract

Objective This study aimed to evaluate and quantify the relationship between coffee and gastric cancer using a uniquely large dataset from an international consortium of observational studies on gastric cancer, including data from 18 studies, for a total of 8198 cases and 21 419 controls. Methods A two-stage approach was used to obtain the pooled odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) for coffee drinkers versus never or rare drinkers. A one-stage logistic mixed-effects model with a random intercept for each study was used to estimate the dose-response relationship. Estimates were adjusted for sex, age and the main recognized risk factors for gastric cancer. Results Compared to never or rare coffee drinkers, the estimated pooled OR for coffee drinkers was 1.03 (95% CI, 0.94-1.13). When the amount of coffee intake was considered, the pooled ORs were 0.91 (95% CI, 0.81-1.03) for drinkers of 1-2 cups per day, 0.95 (95% CI, 0.82-1.10) for 3-4 cups, and 0.95 (95% CI, 0.79-1.15) for five or more cups. An OR of 1.20 (95% CI, 0.91-1.58) was found for heavy coffee drinkers (seven or more cups of caffeinated coffee per day). A positive association emerged for high coffee intake (five or more cups per day) for gastric cardia cancer only. Conclusions These findings better quantify the previously available evidence of the absence of a relevant association between coffee consumption and gastric cancer. © 2022 Lippincott Williams and Wilkins. All rights reserved.